DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Position Reduced by Great West Life Assurance Co. Can
Great West Life Assurance Co. Can cut its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 2.4% during the second quarter, Holdings Channel reports. The firm owned 159,177 shares of the medical instruments supplier’s stock after selling 3,941 shares during the period. Great West Life Assurance Co. Can’s holdings in DENTSPLY SIRONA were worth $10,309,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in XRAY. Howard Hughes Medical Institute boosted its stake in DENTSPLY SIRONA by 134.9% in the first quarter. Howard Hughes Medical Institute now owns 2,751 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 1,580 shares during the period. Penserra Capital Management LLC boosted its stake in shares of DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 240 shares during the period. Howland Capital Management LLC acquired a new stake in shares of DENTSPLY SIRONA during the first quarter worth approximately $203,000. IBM Retirement Fund boosted its stake in shares of DENTSPLY SIRONA by 29.9% in the second quarter. IBM Retirement Fund now owns 3,324 shares of the medical instruments supplier’s stock worth $216,000 after buying an additional 766 shares during the period. Finally, Gilbert & Cook Inc. acquired a new stake in shares of DENTSPLY SIRONA during the second quarter worth approximately $225,000. Institutional investors and hedge funds own 95.17% of the company’s stock.
Shares of DENTSPLY SIRONA Inc. (XRAY) opened at 56.23 on Thursday. DENTSPLY SIRONA Inc. has a 1-year low of $55.00 and a 1-year high of $65.68. The firm has a 50-day moving average price of $63.39 and a 200-day moving average price of $62.35. The stock has a market capitalization of $12.89 billion, a PE ratio of 36.18 and a beta of 1.26.
DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.65. The firm had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a return on equity of 7.37% and a net margin of 9.42%. The firm’s revenue was down 2.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.76 EPS. On average, equities research analysts forecast that DENTSPLY SIRONA Inc. will post $2.84 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be paid a $0.0875 dividend. This represents a $0.35 annualized dividend and a yield of 0.62%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s payout ratio is currently 22.58%.
TRADEMARK VIOLATION WARNING: “DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Position Reduced by Great West Life Assurance Co. Can” was first posted by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.dailypolitical.com/2017/08/10/dentsply-sirona-inc-nasdaqxray-position-reduced-by-great-west-life-assurance-co-can.html.
XRAY has been the subject of several recent analyst reports. Goldman Sachs Group, Inc. (The) lowered DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and lowered their price target for the stock from $60.00 to $55.00 in a research report on Tuesday, May 23rd. Zacks Investment Research raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Wednesday, April 19th. Cleveland Research upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. HC Wainwright began coverage on DENTSPLY SIRONA in a research note on Tuesday, July 11th. They set a “buy” rating and a $74.00 price target for the company. Finally, BidaskClub upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, June 30th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have given a buy rating to the stock. DENTSPLY SIRONA currently has an average rating of “Buy” and a consensus target price of $67.92.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.